about
Surface Proteoglycans as Mediators in Bacterial Pathogens InfectionsMasquerading microbial pathogens: capsular polysaccharides mimic host-tissue moleculesStructural mechanisms underlying sequence-dependent variations in GAG affinities of decorin binding protein A, a Borrelia burgdorferi adhesinPathogenesis and Inhibition of Flaviviruses from a Carbohydrate PerspectiveThe glycointeractome of serogroup B Neisseria meningitidis strain MC58.Endocytosis of viruses and bacteria.Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey.Efficient recovery of glycosaminoglycan oligosaccharides from polyacrylamide gel electrophoresis combined with mass spectrometry analysis.Identification of Functional Determinants in the Chikungunya Virus E2 Protein.Glycosaminoglycans are involved in bacterial adherence to lung cells.Bioengineered heparins and heparan sulfates.The Cryptosporidium parvum C-Type Lectin CpClec Mediates Infection of Intestinal Epithelial Cells via Interactions with Sulfated ProteoglycansSuramin is a potent inhibitor of Chikungunya and Ebola virus cell entryRestoring the glycosaminoglycans layer in recurrent cystitis: experimental and clinical foundations.Antiviral drug discovery: broad-spectrum drugs from nature.Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements.Integrated Approach to Identify Heparan Sulfate Ligand Requirements of Robo1.A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.Different Use of Cell Surface Glycosaminoglycans As Adherence Receptors to Corneal Cells by Gram Positive and Gram Negative PathogensDrug-Mediated Regulation of Glycosaminoglycan Biosynthesis.A histochemical approach to glycan diversity in the urothelium of pig urinary bladder.Hyaluronidase and Chondroitinase.CRISPR/Cas9 Screens Reveal Requirements for Host Cell Sulfation and Fucosylation in Bacterial Type III Secretion System-Mediated CytotoxicityCharacterizing protein-glycosaminoglycan interactions using solution NMR spectroscopy.Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.Glycosaminoglycans from fish swim bladder: isolation, structural characterization and bioactive potential.Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease.Naphthyl Thio- and Carba-xylopyranosides for Exploration of the Active Site of β-1,4-Galactosyltransferase 7 (β4GalT7).Surprising absence of heparin in the intestinal mucosa of baby pigs.Engineered heparins as new anticoagulant drugs.Glycosaminoglycans from chicken muscular stomach or gizzard.Controlled Chemoenzymatic Synthesis of Heparan Sulfate Oligosaccharides.The Bexsero Neisseria meningitidis serogroup B vaccine antigen NHBA is a high-affinity chondroitin sulfate binding protein.Dynamic Structure of Proteoglycans/Glycosaminoglycans in the Lungs of Mice with Chronic Granulomatous Inflammation.Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection.RNA Aptamers with Specificity for Heparosan and Chondroitin GlycosaminoglycansEarly Events in Japanese Encephalitis Virus Infection: Viral Entry
P2860
Q26768544-D6041C3A-9551-4BD4-87C8-CB125829733BQ26865784-93F81A8C-1B34-4694-AF57-CE52EE690476Q27698018-444F34A9-00EA-47E4-AA9C-4693A84CD511Q29994529-6A568B29-757B-4F6D-ADBE-48A6537E21E8Q33915909-DE7BB7CD-057A-4E48-A7ED-A1381368D823Q33938568-3617CCF4-2741-4B87-871C-01E04F139599Q34436057-BD7D735B-D5F5-401D-A7A9-20B1E69512CAQ36188988-B01B7E05-A758-45C2-A31F-14A4481AC4ACQ36257616-615AF497-30B3-4C4F-A7CB-E8FE9D42BFF1Q36361216-D44B2B8E-D09F-4C6A-B4D0-8BA352D081ABQ36578686-7DA5FEB5-33F1-490C-ACF8-20D1D1478B38Q36888570-A2E9F7A7-BBEE-48A8-8580-389DD45AD445Q37224249-8A6C17AD-E687-4D58-A299-5303C021ADA6Q38196864-241299B4-774B-42BE-90F9-B9CE049328A1Q38260235-FFC4C872-395B-49A0-879D-7996BA088265Q38287875-96DC0CBE-8037-43A3-845C-25751E15ED64Q38290964-98109954-4D4E-4E4E-BBA2-979EB24EB3EFQ38329445-954FA21F-76AA-478C-AEC6-1014E9CDDEF3Q38658691-B8740A4F-0C26-4709-A033-57EB8C79FD06Q38726317-1189DC87-E63C-4894-94BE-35C0C294CC9CQ39060517-3E5E447E-A498-4036-8B1C-E9069187DFF1Q39228070-1F5F636A-730A-4EC5-A04F-A4FA39A13E7DQ40563865-8F3E5725-38D8-4947-9CBC-0C9ADAB0FAAEQ40601360-225BD50A-EDF0-44C6-BF95-8891A643ECAEQ41978600-A1A4AA80-D480-43FC-AEB5-204A8AB3867DQ47147327-6C78BB90-8A3C-43D2-B163-5A5718CF178EQ47362819-A7A13885-DD8B-4A54-ABE5-68407F45CA77Q47370006-2A37F9C2-BC7B-45BB-8E2B-D48B7B12BA09Q47575832-4A84297F-DE50-4F81-B6D7-4FA90B301FBCQ47663295-4783D9C5-551F-4117-B273-F38DAA54FFF8Q50870950-FD83AE59-2587-4FAC-A7DD-B62C8AC2F15AQ51135134-A883B99D-A663-4FD4-8AEE-6B430301F5F7Q52364871-8FDBF1DC-6DA7-4806-9CCD-39229787361BQ52562794-A9F02F58-1747-4C59-BAFA-FD89028DF67AQ53168112-459FA455-212E-45C6-9A0E-838F913DE9D7Q53625004-CF9D66B2-B989-48DE-A58E-B51B93BF7166Q58581033-F3771B24-EF62-43BE-94FA-F90BEFBF1E8CQ58784010-C3AF38ED-7CD9-4924-8A82-42E7C536FEF3
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Glycosaminoglycans in infectious disease.
@en
type
label
Glycosaminoglycans in infectious disease.
@en
prefLabel
Glycosaminoglycans in infectious disease.
@en
P2860
P356
P1433
P1476
Glycosaminoglycans in infectious disease.
@en
P2093
Eun Ji Joo
Eyal Kamhi
P2860
P304
P356
10.1111/BRV.12034
P577
2013-03-29T00:00:00Z